Drug Shortage Report for HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION

Last updated on 2020-06-17 History
Report ID 107741
Drug Identification Number 01990748
Brand name HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION
Common or Proper name Heparin
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) HEPARIN SODIUM
Strength(s) 2UNIT
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 18 x 500ML PLBG
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-03-02
Estimated end date
Actual end date 2020-06-16
Shortage status Resolved
Updated date 2020-06-17
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2020-06-17 English Compare
v8 2020-06-16 French Compare
v7 2020-06-16 English Compare
v6 2020-03-04 French Compare
v5 2020-03-04 English Compare
v4 2020-03-04 French Compare
v3 2020-03-04 English Compare
v2 2020-03-04 French Compare
v1 2020-03-04 English Compare